Phosphor screen scanners are medical devices used for the detection and diagnosis of various types of cancers. They allow quick and accurate imaging of tissues and cells through specialized phosphor screens. Some key advantages of these scanners include high resolution imaging capability, minimal radiation exposure to patients, ease of use, and ability to detect even the smallest abnormalities at an early stage. The growing awareness about early cancer detection and rising incidence of diseases like breast cancer, lung cancer and prostate cancer have significantly boosted the demand for phosphor screen scanners in recent years. The global Phosphor Screen Scanner Market is estimated to be valued at US$ 288 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing demand for early cancer detection is one of the major factors driving the growth of the phosphor screen scanner market. Early detection of cancers highly increases the chances of complete cure and recovery. Phosphor screen scanners allow detection of tumors as small as few millimeters, which was difficult to detect with conventional radiography methods. This has led to higher adoption of these scanners by healthcare facilities and diagnostic centers. Development of advanced digital phosphor screen scanners with capabilities like faster scan times, high resolution and sensitivity is further supporting the market growth. Manufacturers are continuously innovating their products to provide better solutions for early stage cancer detection applications.
Segment Analysis
The global phosphor screen scanner market size is dominated by the medical imaging segment. This segment accounts for over 60% of the total market share due to the widespread usage of phosphor screen scanners in medical imaging applications like X-ray imaging, dental radiography, and fluoroscopy. Phosphor screens are used in medical imaging equipment as an X-ray detector, and scanners are used to digitize the phosphor screen for medical diagnosis.
Key Takeaways
The global phosphor screen scanner market is expected to witness high growth over the forecast period from 2024 to 2031.
Regional analysis: North America is currently the dominant region in the global phosphor screen scanner market. This is attributed to the large base of medical imaging equipment and favorable medical reimbursement policies in countries like the US and Canada. Moreover, the presence of leading market players like Intomics and Thermo Fisher Scientific in the region further augment the market growth. Europe is the second largest regional market and is expected to have highest growth over the coming years owing to improving healthcare infrastructure and rising investment in medical research in nations like Germany, UK, and France.
Key players operating in the phosphor screen scanner market are Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Foundational Therapeutics. Intomics is a market leader in the North American and European region for phosphor screen scanners owing to its wide product portfolio and widespread geographical presence.
Get more insights on this topic: https://www.newsstatix.com/phosphor-screen-scanner-market-share-and-opportunity-analysis/
Comments
0 comment